Elanix Biotechnologies AG (DB:ELN) announced a private placement of common shares for gross proceeds of €2.5 million on April 30, 2018. The company will receive funding through equity line financing. The transaction will include participation from new investor Yorkville Advisors Global LP. The facility will be availed over a period of 24 months.